跳至主要内容
临床试验/CTRI/2019/08/020614
CTRI/2019/08/020614尚未招募4 期

Effect of desensitisation with intravenous lignocaine in fibromyalgia patient - a prospective study

ESI Institute of Pain Management0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from fibromyalgia with Widespread Pain Index(WPI)more than 7 and Symptom Severity Index(SSS) more than 5 or WPI 4-6 and SSS more than 9
  • 2. Duration of fibromyalgia more than 12 weeks
  • 3. Patient taking anti-neuropathic medicine more than 4 weeks
  • 4. Degree of pain more than 5 according to VAS

排除标准

  • 1. Patients with allergy to lignocaine
  • 2. History of cardiac dysrrythmias
  • 3. Patients with severe hepatic and renal disease
  • 4. Patients not giving consent
  • 5. Poorly controlled psychiatric conditions with possible secondary gain or severe comorbidity.

研究者

发起方
ESI Institute of Pain Management

相似试验